APAC Healthcare Weekly (November 16) – Leads Bio, Henlius Bio, Otsuka, ABL Bio, Boryung, Eubiologics
Henlius got FDA approval for Perjeta biosimilar. Otsuka reports positive Phase 3 trial result for sibepernlimab. ABL Bio signed deal with Lilly....
447 Views
United Lab Placement - Industry Momentum Strong, Although Stock Has Run-Up Quite a Bit
United Laboratories International Holdings is looking to raise up to US$262m from a primary placement. In this note, we will talk about the...
587 Views
Pre-IPO JBM Healthcare Ltd. - Could JBM Break the Ice?
This article analyzed JBM Healthcare from the prospective of market potential, supplier concentration, and financial position, and summarized the...
699 Views
Trade Idea: Short Henlius Upon Lock-Up Expiry & 2H Results, HLX01 Likely Underperformed
Shanghai Henlius Biotech (2696 HK) IPO lock-up will expire on 25th of March, six months post its listing. The stock has been underwater since...
463 Views
Hong Kong Buyback Weekly: Fosun Intl, Link REIT, Viva Biotech
Hong Kong Exchange publishes share repurchases by listed companies on a daily basis. In our weekly note, we will provide statistics on top...
418 Views